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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER1125Paravalvular Leak After Transcatheter Aortic Valve ReplacementPhilippe Généreux, Stuart J. Head, Rebecca Hahn, Benoit Daneault, Susheel Kodali, Mathew R. Williams,
Nicolas M. van Mieghem, Maria C. Alu, Patrick W. Serruys, A. Pieter Kappetein, Martin B. Leon
Paravalvular leak (PVL) is a frequent complication of transcatheter aortic valve replacement
(TAVR). Recent reports indicating that PVL may increase late mortality have raised further
concerns. However, there has been heterogeneity of methods for assessing and quantifying
PVL, and in the timing of such assessments. Généreux and colleagues reviewed the literature
in an effort to consolidate current knowledge in this area, better understand the prevalence,
progression, and impact of post-TAVR PVL, and to help direct future efforts in this area.SPECIAL ARTICLE SPECIAL ARTICLE
1137Authors’ Self-Declared Financial Conflicts of Interest
Do Not Impact the Results of Major Cardiovascular TrialsAshish Aneja, Ricardo Esquitin, Kshitij Shah, Rupa Iyengar, Rosane Nisenbaum, Magda Melo,
Shiny Matthewkutty, Sanjum S. Sethi, Muhammad Mamdani, Michael E. Farkouh
This study assessed whether the results of major cardiovascular trials were influenced by the
authors’ self-declared financial conflicts of interest (FCOI). Aneja and colleagues performed a
MEDLINE search of cardiovascular clinical trials in New England Journal of Medicine, JAMA
or the Lancet from 2000 through 2008. Of the 550 articles reviewed, 51% had at least 1
FCOI criteria. FCOI prevalence significantly increased with higher levels of industry funding.
However, there were no differences in reporting of favorable results when articles were
analyzed by self-declared FCOI. These results suggest that authors’ self-declared FCOI and
the source of funding do not impact outcomes in major cardiovascular clinical trials.
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ECARDIOMETABOLIC RISK1146Extreme Lipoprotein(a) Levels Improve Cardiovascular Risk PredictionPia R. Kamstrup, Anne Tybjærg-Hansen, Børge G. Nordestgaard
Kamstrup and colleagues tested whether extreme lipoprotein(a) levels and/or corresponding
LPA risk genotypes improve myocardial infarction (MI) and coronary heart disease (CHD)
risk prediction beyond conventional risk factors. For individuals with lipoprotein(a) levels
80th percentile (47 mg/dl), 23% of MI events and 12% of CHD events were reclassified
correctly in a cohort of approximately 10,000 Danish subjects. Addition of lipoprotein(a)
levels 80th percentile yielded net reclassification indices of 16% and 3% for MI and
HD and was particularly useful in individuals at 10.0% to 19.9% absolute 10-year MI and
HD risk. Identifying patients with marked elevation in lipoprotein(a) levels may helpmprove CHD risk prediction.HEART FAILURE
1157Contrasting Effects of Lower Body Positive Pressure in
Men With HF and OSA or CSATakatoshi Kasai, Shveta S. Motwani, Dai Yumino, Joseph M. Gabriel, Luigi Taranto Montemurro,
Vinoban Amirthalingam, John S. Floras, T. Douglas Bradley
Kasai and colleagues tested the effects of rostral fluid displacement from the legs on
pharyngeal resistance (Rph), minute volume of ventilation (Vmin) and PCO2 in men with
eart failure (HF), and either obstructive or central sleep apnea (OSA or CSA, respectively).
ubjects were studied while wearing anti-shock trousers while deflated (control) or inflated for
5 min (lower body positive pressure [LBPP]). LBPP reduced leg fluid volume and increased
eck circumference. In men with OSA, LBPP induced an increase in Rph, a decrease in
min, and an increase in PCO2; in the group with CSA, LBPP induced the opposite—a
eduction in Rph, an increase in Vmin, and a reduction in PCO2. These findings suggest
echanisms by which rostral fluid shift contributes to the pathogenesis of both OSA and
SA in men with HF.
ditorial Comment: Michele Emdin, Claudio Passino, Alberto Giannoni, p. 1167(continued on page A-25)
MARCH 19, 2013 (continued) A-25HYPERTROPHIC CARDIOMYOPATHY
1169Blunted Myocardial Oxygenation Response
During Vasodilator Stress in Patients With HCMTheodoros D. Karamitsos, Sairia Dass, Joseph Suttie, Emily Sever, Jacqueline Birks, Cameron J. Holloway,
Matthew D. Robson, Michael Jerosch-Herold, Hugh Watkins, Stefan Neubauer
Myocardial perfusion under vasodilator stress is impaired in patients with hypertrophic
cardiomyopathy (HCM), but whether this is associated with impaired myocardial oxygenation
and tissue ischemia is unknown. A total of 27 patients with overt HCM, 10 HCM mutation
carriers without left ventricular hypertrophy (LVH), 11 athletes, and 20 healthy controls
underwent cardiovascular magnetic resonance scanning including myocardial perfusion
(perfusion reserve index-MPRI) and oxygenation (blood-oxygen level-dependent signal
intensity change) with adenosine. MPRI was significantly reduced in HCM compared to
controls, athletes, and HCM mutation carriers without LVH. Oxygenation response was
attenuated in overt HCM and HCM mutation carriers compared to controls and athletes.
These results show that in HCM patients both perfusion and oxygenation are impaired
during vasodilator stress, and in HCM mutation carriers without LVH, oxygenation is
impaired.HEART RHYTHM DISORDERS
1177Yoga Appears to Decrease Arrhythmia Burden,
Anxiety, and Depression in Patients With Paroxysmal AFDhanunjaya Lakkireddy, Donita Atkins, Jayasree Pillarisetti, Kay Ryschon, Sudharani Bommana,
Jeanne Drisko, Subba Reddy Vanga, Buddhadeb Dawn
The ‘YOGA My Heart’ Study examined the impact of yoga on atrial fibrillation (AF)
burden, quality of life (QoL), and depression and anxiety scores in patients with
paroxysmal AF. Subjects with symptomatic paroxysmal AF underwent an initial
3-month noninterventional observation period followed by twice weekly 60-min yoga
training sessions for 3 months. Yoga training reduced symptomatic AF episodes,
symptomatic non-AF episodes, and asymptomatic AF episodes. Patients with paroxysmal
AF may benefit from the practice of yoga and a randomized study appears warranted.(continued on page A-26)
MARCH 19, 2013 (continued) A-26HEART RHYTHM DISORDERS1183Long-Term Follow-Up of a Pediatric Cohort With SQTSJuan Villafañe, Joseph Atallah, Michael H. Gollob, Philippe Maury, Christian Wolpert, Roman Gebauer,
Hiroshi Watanabe, Minoru Horie, Olli Anttonen, Prince Kannankeril, Brett Faulknier, Jorge Bleiz,
Takeru Makiyama, Wataru Shimizu, Robert M. Hamilton, Ming-Lon Young
Villafañe and colleagues report the results of an international case series of 25
patients 21 years of age with short QT syndrome (SQTS). SQTS was defined as a QT
interval 330 ms or, QTc 360 ms with arrhythmia history, and/or positive family
history of SQTS/unexplained sudden cardiac death (SCD). Symptoms occurred in 14 of
25 patients (56%) including: aborted SCD in 24% and syncope in 16%. Arrhythmias
were common: atrial fibrillation (n  4), ventricular fibrillation (n  6), supraventricular
tachycardia (SVT) (n  1), and polymorphic ventricular tachycardia (n  1). Ten
patients received medical treatment, mainly with quinidine. Eleven of 25 patients
underwent implantable cardioverter-defibrillator (ICD) implantation: 22% had
appropriate ICD shocks, but inappropriate ICD shocks were observed in 64%. These
results help to define the clinical outcomes of pediatric patients with SQTS.PRE-CLINICAL RESEARCH PRE-CLINICAL RESEARCH
1192HCN2/SkM1 Gene Transfer Into Canine LBB
Induces Stable, Physiologic PacingGerard J. J. Boink, Lian Duan, Bruce D. Nearing, Iryna N. Shlapakova, Eugene A. Sosunov,
Evgeny P. Anyukhovsky, Eugene Bobkov, Yelena Kryukova, Nazira Ozgen, Peter Danilo, Jr, Ira S. Cohen,
Richard L. Verrier, Richard B. Robinson, Michael R. Rosen
Gene-based biological pacemakers display effective in vivo pacemaker function, but have not
yet been designed to produce basal beating rates of 60 to 90 beats/min and a brisk autonomic
response. Boink and colleagues tested the hypothesis that hyperpolarization-activated cyclic
nucleotide-gated (HCN)-based biological pacing could be improved via co-expression of the
skeletal muscle sodium channel (SkM1). Adenoviral SkM1, HCN2, or HCN2/SkM1
constructs were injected into left bundle branches (LBB) of atrioventricular-blocked dogs.
HCN2/SkM1 LBB-injected dogs showed highly stable in vivo pacemaker activity superior to
SkM1 or HCN2 alone with regard to beating rates (resting 80 beats/min, maximum 130
beats/min), absent dependence on electronic backup pacing, and enhanced modulation of
pacemaker function during circadian rhythm or epinephrine infusion. Adding SkM1 to
HCN2 constructs potentially provides a more clinically suitable biological pacemaker strategy
than other constructs reported.Editorial Comment: Matteo Vatta, Douglas P. Zipes, p. 1202
